These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33023265)

  • 1. Point-of-Care Tests for Hepatitis B: An Overview.
    Xiao Y; Thompson AJ; Howell J
    Cells; 2020 Oct; 9(10):. PubMed ID: 33023265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New virological tools for screening, diagnosis and monitoring of hepatitis B and C in resource-limited settings.
    Chevaliez S; Pawlotsky JM
    J Hepatol; 2018 Oct; 69(4):916-926. PubMed ID: 29800630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia.
    Bajis S; Maher L; Treloar C; Hajarizadeh B; Lamoury FMJ; Mowat Y; Schulz M; Marshall AD; Cunningham EB; Cock V; Ezard N; Gorton C; Hayllar J; Smith J; Whelan M; Martinello M; Applegate TL; Dore GJ; Grebely J;
    Int J Drug Policy; 2018 Nov; 61():23-30. PubMed ID: 30388566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Where we are with point-of-care testing.
    Johannessen A
    J Viral Hepat; 2015 Apr; 22(4):362-5. PubMed ID: 25762459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innovative technologies for point-of-care testing of viral hepatitis in low-resource and decentralized settings.
    Duchesne L; Lacombe K
    J Viral Hepat; 2018 Feb; 25(2):108-117. PubMed ID: 29134742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring hepatitis B by using point-of-care testing: biomarkers, current technologies, and perspectives.
    Rong X; Ailing F; Xiaodong L; Jie H; Min L
    Expert Rev Mol Diagn; 2021 Feb; 21(2):195-211. PubMed ID: 33467927
    [No Abstract]   [Full Text] [Related]  

  • 7. Tenofovir for prevention of mother to child transmission of hepatitis B in migrant women in a resource-limited setting on the Thailand-Myanmar border: a commentary on challenges of implementation.
    Bierhoff M; Rijken MJ; Yotyingaphiram W; Pimanpanarak M; van Vugt M; Angkurawaranon C; Nosten F; Ehrhardt S; Thio CL; McGready R
    Int J Equity Health; 2020 Sep; 19(1):156. PubMed ID: 32912268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling of hypothetical SARS-CoV-2 point-of-care tests on admission to hospital from A&E: rapid cost-effectiveness analysis.
    Stevenson M; Metry A; Messenger M
    Health Technol Assess; 2021 Mar; 25(21):1-68. PubMed ID: 33764295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point-of-care hepatitis C testing from needle and syringe programs: An Australian feasibility study.
    Williams B; Howell J; Doyle J; Thompson AJ; Draper B; Layton C; Latham N; Bramwell F; Membrey D; Mcpherson M; Roney J; Stoové M; Hellard ME; Pedrana A
    Int J Drug Policy; 2019 Oct; 72():91-98. PubMed ID: 31129023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical performance of newly developed rapid point-of-care test for the simultaneous detection of hepatitis A, B, and C viruses in serum samples.
    Kweon OJ; Lim YK; Kim HR; Kim TH; Lee MK
    J Med Virol; 2019 Jun; 91(6):1056-1062. PubMed ID: 30668895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining rapid diagnostic tests and dried blood spot assays for point-of-care testing of human immunodeficiency virus, hepatitis B and hepatitis C infections in Burkina Faso, West Africa.
    Kania D; Bekalé AM; Nagot N; Mondain AM; Ottomani L; Meda N; Traoré M; Ouédraogo JB; Ducos J; Van de Perre P; Tuaillon E
    Clin Microbiol Infect; 2013 Dec; 19(12):E533-41. PubMed ID: 23902574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2017 European guideline for the screening, prevention and initial management of hepatitis B and C infections in sexual health settings.
    Brook G; Brockmeyer N; van de Laar T; Schellberg S; Winter AJ
    Int J STD AIDS; 2018 Sep; 29(10):949-967. PubMed ID: 29716442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markov modeling in hepatitis B screening and linkage to care.
    Sehr MA; Joshi KD; Fontanesi JM; Wong RJ; Bitmead RR; Gish RG
    Theor Biol Med Model; 2017 May; 14(1):11. PubMed ID: 28521828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model-based cost-effectiveness estimates of testing strategies for diagnosing hepatitis C virus infection in Central and Western Africa.
    Duchesne L; Hejblum G; Njouom R; Touré Kane C; Toni TD; Moh R; Sylla B; Rouveau N; Attia A; Lacombe K
    PLoS One; 2020; 15(8):e0238035. PubMed ID: 32833976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas12-Based Ultra-Sensitive and Specific Point-of-Care Detection of HBV.
    Ding R; Long J; Yuan M; Zheng X; Shen Y; Jin Y; Yang H; Li H; Chen S; Duan G
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34063629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B and hepatitis C in southeast and southern Asia: challenges for governments.
    Wait S; Kell E; Hamid S; Muljono DH; Sollano J; Mohamed R; Shah S; Mamun-Al-Mahtab ; Abbas Z; Johnston J; Tanwandee T; Wallace J
    Lancet Gastroenterol Hepatol; 2016 Nov; 1(3):248-255. PubMed ID: 28404097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B screening in an argentine ED: Increasing vaccination in a resource-limited setting.
    Ford JS; Marianelli LG; Frassone N; Debes JD
    Am J Emerg Med; 2020 Feb; 38(2):296-299. PubMed ID: 31353159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CLIA-waived molecular influenza testing in the emergency department and outpatient settings.
    Babady NE; Dunn JJ; Madej R
    J Clin Virol; 2019 Jul; 116():44-48. PubMed ID: 31102924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant decrease in the prevalence of hepatitis C infection after the introduction of direct acting antivirals.
    Rodríguez-Tajes S; Domínguez Á; Carrión JA; Buti M; Quer JC; Morillas RM; López C; Torras X; Baliellas C; Vergara M; Forner M; Zaragoza N; Salò J; Rigau J; Caballeria L; Mariño Z; Janè M; Colom J; Forns X; Lens S
    J Gastroenterol Hepatol; 2020 Sep; 35(9):1570-1578. PubMed ID: 31957902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decentralized, Community-Based Hepatitis C Point-of-Care Testing and Direct-Acting Antiviral Treatment for People Who Inject Drugs and the General Population in Myanmar: Protocol for a Feasibility Study.
    Draper BL; Pedrana A; Howell J; Yee WL; Htay H; Aung KS; Shilton S; Kyi KP; Naing W; Hellard M
    JMIR Res Protoc; 2020 Jul; 9(7):e16863. PubMed ID: 32673260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.